Skip to main content
Clinical Trials/NCT05056012
NCT05056012Not yet recruitingNot Applicable

Penn Sjögren's International Clinical Collaborative Alliance (SICCA) Follow-up Study

University of Pennsylvania2 sites in 1 country220 target enrollmentStarted: January 1, 2027Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
220
Locations
2
Primary Endpoint
Collection of specimens and clinical information

Study Overview

Brief Summary

This study will involve the collection of follow-up data for patients who previously participated in the Sjogren's International Clinical Collaborative Alliance (SICCA) study at the University of Pennsylvania. Clinical data and specimens will be collected from subjects with objective evidence of dry eye who were or were not diagnosed with Sjogren's syndrome at the time of their initial participation in the SICCA study. Specimens will be collected from participants which will include tears, saliva, whole blood, serum, DNA and possible labial minor salivary gland biopsies when indicated. All individuals will participate in a standard evaluation protocol including an oral, ocular and physical examination, objective tests for dry eyes and dry mouth and, whenever necessary, a labial minor salivary gland biopsy. The biopsy requirement is waived for those who have already had positive lip biopsies in the past.

Detailed Description

General study design: This is a single center study that involves follow-up of patients who previously participated in the Sjogren's International Collaborative Clinical Alliance (SICCA) at the University of Pennsylvania. Objective evaluation of salivary function will be done by collecting unstimulated whole and stimulated parotid saliva. Objective evaluation of lacrimal function will be performed using the Schirmer test I, Lissamine Green staining, and determining tear break-up time. In a subset of patients, when indicated an objective evaluation of lymphocytic infiltration of the minor salivary glands will be performed by histologic analysis of labial salivary gland biopsies. Serum autoantibody profiles will be determined. In addition, specimens such as biopsies, saliva, sera, conjunctival cells, and tears will be collected. Standardized questionnaires will be used to gain health information.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Previously participated in the SICCA study at Penn
  • Be 18 years or older
  • 4. Have signed an IRB consent form agreeing to the terms of the study

Exclusion Criteria

  • Did not previously participate in SICCA study at Penn
  • Under the age of 18 years

Outcomes

Primary Outcomes

Collection of specimens and clinical information

Time Frame: 2 years

To collect specimens (saliva, tears, conjunctival cells, and blood) and clinical information on dry eye patients with or without Sjogren's syndrome

Secondary Outcomes

  • Serologic testing(2 years)
  • Ocular surface exam findings(2 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Vatinee Bunya, MD

Co-Director of Penn Dry Eye & Ocular Surface Center

University of Pennsylvania

Study Sites (2)

Loading locations...

Similar Trials

Penn SICCA Follow-up Study | Clinical Trial